![Meg M. Silverman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ms. Meg M.
Silverman is Head of Investor Relations at Thomas, McNerney & Partners LLC.
She joined the firm in 2010.
She has extensive experience in the venture capital industry.
Previously, she was Partner-US Investor Relations at Advent Ventures Life Sciences, and before that she spent thirteen years at HealthCare Ventures LLC, previously as Director of LP Relations and Director of Administration.
While at Advent and HealthCare, she was instrumental in raising over $800 million.
Ms. Silverman has a wide-ranging knowledge of the biotechnology industry, including an in-depth understanding of pharmaceutical clinical research and regulatory filings, having concentrated on these areas earlier in her career at The Liposome Company, Inc., a publicly traded biotechnology company subsequently acquired by Elan; Biodecision Incorporated, a clinical research organization; and Shadyside Hospital, a major teaching and research hospital.
Anciens postes connus de Meg M. Silverman
| Sociétés | Poste | Fin |
|---|---|---|
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Public Communications Contact | 31/08/2011 |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Corporate Officer/Principal | - |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Thomas, McNerney & Partners LLC
Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Finance |
Choisissez Zonebourse 
